Показаны сообщения с ярлыком obesity. Показать все сообщения
Показаны сообщения с ярлыком obesity. Показать все сообщения

понедельник, 8 сентября 2025 г.

Scientists Discover New Fat Cell Types, Transforming Obesity Research

 

Brown fat cell rich in mitochondria and having lipid droplets scattered throughout, 27 July 2018. (Scientific Animations/Creative Commons)

Veronica Neifakh

Findings reveal unique fat cell subpopulations, paving the way for personalized treatments for obesity

A groundbreaking international study has revealed a new level of complexity within human fat tissue, identifying distinct subpopulations of fat cells with specialized functions. Published in Nature Genetics, the Israeli-led research is the first to characterize the diversity of fat cells in subcutaneous and visceral fat tissues, shedding light on the cells’ role in health and disease.

Using innovative RNA-mapping technology, the researchers uncovered previously unidentified subtypes of fat cells and differences in intercellular communication within fat tissues. This discovery challenges the long-held view that fat cells, also known as adipocytes, merely store and release energy. Instead, the study confirms that fat tissue plays an active role in regulating key physiological processes through signals to the brain, blood vessels, liver, and pancreas. The findings could pave the way for more precise, personalized treatments for obesity and metabolic diseases.

The research was led by Esti Yeger-Lotem and Assaf Rudich from Ben-Gurion University of the Negev, in collaboration with Naomi Habib from the Hebrew University of Jerusalem, Matthias Blüher, Antje Körner, and Martin Gericke from Leipzig University, Germany, and Rinki Murphy from the University of Auckland, New Zealand.

Esti Yeger-Lotem, one of the lead researchers from Ben-Gurion University of the Negev, told The Media Line that most of the cells were “classical” fat cells. Research revealed a new subtype of fat cells with much higher mitochondrial content than others, suggesting that these cells might have a different function.

“This research gives us a new lens to look at fat tissue,” Yeger-Lotem said. “It’s not just about storing energy—these cells are playing a much bigger role in human health than we ever realized.”

Now, she said, the challenge is to understand the functions of the different fat cell types and how they relate to disease.

One of the fundamental questions the research aims to answer is why different fat tissues in the body behave differently. It has long been known that subcutaneous fat (beneath the skin) and visceral fat (around internal organs) function differently, with visceral fat being more inflammatory and more closely linked to metabolic diseases. Previous studies suggested that the cellular composition of these fat tissues was surprisingly similar.

“We knew that these two fat tissues were functionally and molecularly different,” researcher Assaf Rudich told The Media Line. “But previous studies looking at cell types in the tissues showed that they were too similar, which didn’t add up. We set out to find the more subtle differences that could explain this contradiction.”

The researchers found that the key difference was not in the kind of fat cells in each tissue but in how fat cells communicate within the tissue types.

“The differences were not where we initially expected them to be,” Rudich said. Rather than finding completely different types of fat cells in subcutaneous versus visceral fat, the researchers “found significant differences in how cells within each tissue interact and regulate gene expression.”

This discovery highlights that fat tissue function is determined not just by cell types, but also by complex signaling networks—which could be another key to understanding obesity-related diseases.

Another unexpected finding involved how fat cells develop over time. Originally, the researchers hypothesized that classical fat cells evolve into more specialized cells as part of their maturation process. But their analysis suggested the exact opposite.


https://tinyurl.com/5ddfyhfw

пятница, 16 января 2015 г.

First anti-obesity electronic implant wins US approval

A tummy implant could zap those binges <i>(Image: Getty)</i>
by Clare Wilson

From crash diets to stomach-stapling and jaw-wiring, it seems there's nothing people won't try to lose weight. Soon you may even be able to have an implant, one that works by blocking signals between the stomach and the brain.
The device, called the Maestro Rechargeable System, has just been approved by the US Food and Drug Administration for people who are both severely obese – defined as those with a body mass index over 35 – and have a weight-related condition such as diabetes. Once fitted, it is recharged and adjusted wirelessly using an external controller. It is due to go on sale in the US later this year, with sales in other countries to follow.
The device doesn't seem to be the long-sought cure for obesity, though, as it leads to only modest weight loss – about 9 per cent. That compares with a 6 per cent weight loss in people who had a sham operation, in which the device was fitted but the electrodes were not connected.

Bypass or no?

"That's not a game changer," says Nick Finer of University College Hospital in London. If people are going to have surgery they would be better off having a gastric bypass, he suggests, which leads to greater weight loss. "It's extremely safe and durable."
However, obesity surgeon Scott Shikora, speaking for the device's manufacturer, EnteroMedics, says that some people dislike the idea of having their intestines "replumbed". "A lot of patients don't want the operations we are currently performing because they view them as being too risky or too radical," he says.
In a year-long trial of the Maestro system in 239 people, there were few serious side effects. But people who got the real implant were more likely to have indigestion, abdominal pain or nausea.
The company has not yet published the results of longer-term trials. But Shikora says one of these, smaller than the year-long study, suggests people's weight loss seems to plateau after about a year but is maintained for at least five years.

Vagus nerve

The signals blocked by the device travel along the vagus nerve, an important line of communication between the brain and several major organs. The electrodes wrap around the branch of the nerve connecting to the stomach. This contains both the neurons going from the stomach to the brain and those going back down to the stomach.
According to EnteroMedics, blocking this signalling pathway reduces stomach expansion and contraction, as well as the secretion of digestive enzymes. The net result is that people feel less hungry and their calorie intake is reduced.
"There's a treatment gap between diet and exercise and conventional surgery," says Shikora. "This would fit nicely between the two."
Other conditions can be treated by devices that stimulate the vagus nerve. A neck implant is used to reduce seizures in people with epilepsy, for instance, and a similar approach is being investigated to treat headaches, depression and tinnitus.